Top

Published in:

2011 | OriginalPaper | Chapter

Tissue Engineering for Cardiac Regeneration

Authors : Roberto Gaetani, Pieter A. F. Doevendans, Elisa Messina, Joost P. G. Sluijter

Published in: Myocardial Tissue Engineering

Publisher: Springer Berlin Heidelberg

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

Tissue engineering is an interdisciplinary field that involves engineering, chemistry, biology and medicine and is emerging in the last decade as a possible approach to regenerate an injured organ by using cells, matrix, biological active molecules and physiologic stimuli. In the cardiovascular field, cardiac tissue engineering (CTE) is suggested as an alternative approach for direct cell transplantation and aims to regenerate an injured myocardial ventricular wall or to repair congenital defects. This chapter will focus on the strategies developed for CTE and in particular on materials and cells used and the advantages that CTE could offers compared to conventional cell therapy.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

inform now

next chapter Inherently Bio-Active Scaffolds: Intelligent Constructs to Model the Stem Cell Niche

Udelson, J.E., Patten, R.D., Konstam, M.A.: New concepts in post-infarction ventricular remodeling. Rev. Cardiovasc. Med. 4(Suppl 3), S3–S12 (2003)

Anversa, P., Li, P., Zhang, X., et al.: Ischaemic myocardial injury and ventricular remodelling. Cardiovasc. Res. 27(2), 145–157 (1993)CrossRef

Gaetani, R., Barile, L., Forte, E., et al.: New perspectives to repair a broken heart. Cardiovasc. Hematol. Agents. Med. Chem. 7(2), 91–107 (2009)CrossRef

Menasche, P., Hagege, A.A., Vilquin, J.T., et al.: Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41(7), 1078–1083 (2003)CrossRef

Assmus, B., Schachinger, V., Teupe, C., et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106(24), 3009–3017 (2002)CrossRef

Schachinger, V., Assmus, B., Britten, M.B., et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J. Am. Coll. Cardiol. 44(8), 1690–1699 (2004)CrossRef

Wollert, K.C., Meyer, G.P., Lotz, J., et al.: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364(9429), 141–148 (2004)CrossRef

Meyer, G.P., Wollert, K.C., Lotz, J., et al.: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113(10), 1287–1294 (2006)CrossRef

Robey, T.E., Saiget, M.K., Reinecke, H., et al.: Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell Cardiol. 45(4), 567–581 (2008)CrossRef

10.

Zimmermann, W.H., Cesnjevar, R.: Cardiac tissue engineering: implications for pediatric heart surgery. Pediatr. Cardiol. 30(5), 716–723 (2009)CrossRef

11.

Akhyari, P., Kamiya, H., Haverich, A., et al.: Myocardial tissue engineering: the extracellular matrix. Eur. J. Cardiothorac. Surg. 34(2), 229–241 (2008)CrossRef

12.

Radisic, M., Yang, L., Boublik, J., et al.: Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 286(2), H507–H516 (2004)CrossRef

13.

Brown, M.A., Iyer, R.K., Radisic, M.: Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol. Prog. 24(4), 907–920 (2008)CrossRef

14.

Fink, C., Ergun, S., Kralisch, D., et al.: Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. Faseb J. 14(5), 669–679 (2000)

15.

Zhang, M., Methot, D., Poppa, V., et al.: Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell Cardiol. 33(5), 907–921 (2001)CrossRef

16.

Hudson, W., Collins, M.C., deFreitas, D., et al.: Beating and arrested intramyocardial injections are associated with significant mechanical loss: implications for cardiac cell transplantation. J. Surg. Res. 142(2), 263–267 (2007)CrossRef

17.

Freyman, T., Polin, G., Osman, H., et al.: A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur. Heart J. 27(9), 1114–1122 (2006)

18.

Hayashi, M., Li, T.S., Ito, H., et al.: Comparison of intramyocardial and intravenous routes of delivering bone marrow cells for the treatment of ischemic heart disease: an experimental study. Cell Transpl. 13(6), 639–647 (2004)CrossRef

19.

Reinecke, H., Zhang, M., Bartosek, T., et al.: Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100(2), 193–202 (1999)

20.

Zvibel, I., Smets, F., Soriano, H.: Anoikis: roadblock to cell transplantation? Cell Transpl. 11(7), 621–630 (2002)

21.

Nakamura, Y., Yasuda, T., Weisel, R.D., et al.: Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function. Am. J. Physiol. Heart Circ. Physiol. 291(2), H939–H947 (2006)CrossRef

22.

Li, W., Ma, N., Ong, L.L., et al.: Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25(8), 2118–2127 (2007)CrossRef

23.

Azarnoush, K., Maurel, A., Sebbah, L., et al.: Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. J. Thorac. Cardiovasc. Surg. 130(1), 173–179 (2005)CrossRef

24.

Maurel, A., Azarnoush, K., Sabbah, L., et al.: Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? Transplantation 80(5), 660–665 (2005)CrossRef

25.

Jayakumar, J., Suzuki, K., Sammut, I.A., et al.: Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation 104(12 Suppl 1), I303–I307 (2001)

26.

Liu, T.B., Fedak, P.W., Weisel, R.D., et al.: Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation. Am. J. Physiol. Heart Circ. Physiol. 287(6), H2840–H2849 (2004)CrossRef

27.

Laflamme, M.A., Chen, K.Y., Naumova, A.V., et al.: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25(9), 1015–1024 (2007)CrossRef

28.

Davis, M.E., Hsieh, P.C., Takahashi, T., et al.: Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc. Natl. Acad. Sci. USA 103(21), 8155–8160 (2006)CrossRef

29.

Retuerto, M.A., Schalch, P., Patejunas, G., et al.: Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J. Thorac. Cardiovasc. Surg. 127(4), 1041–1049 (2004). discussion 1049–1051CrossRef

30.

Wang, Y., Haider, H.K., Ahmad, N., et al.: Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J. Mol. Cell Cardiol. 40(5), 736–745 (2006)CrossRef

31.

Matsumoto, R., Omura, T., Yoshiyama, M., et al.: Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 25(6), 1168–1173 (2005)CrossRef

32.

Suzuki, K., Murtuza, B., Beauchamp, J.R., et al.: Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. Faseb J. 18(10), 1153–1155 (2004)

33.

Hsieh, P.C., Davis, M.E., Gannon, J., et al.: Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest. 116(1), 237–248 (2006)

34.

Padin-Iruegas, M.E., Misao, Y., Davis, M.E., et al.: Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 120(10), 876–887 (2009)CrossRef

35.

Muller-Ehmsen, J., Krausgrill, B., Burst, V., et al.: Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J. Mol. Cell Cardiol. 41(5), 876–884 (2006)CrossRef

36.

Hou, D., Youssef, E.A., Brinton, T.J., et al.: Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112(Suppl 9), I150–I156 (2005)

37.

Terrovitis, J., Lautamaki, R., Bonios, M., et al.: Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J. Am. Coll. Cardiol. 54(17), 1619–1626 (2009)CrossRef

38.

Kutschka, I., Chen, I.Y., Kofidis, T., et al.: Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 114(Suppl 1), I167–I173 (2006)

39.

Kutschka, I., Chen, I.Y., Kofidis, T., et al.: In vivo optical bioluminescence imaging of collagen-supported cardiac cell grafts. J. Heart Lung Transpl. 26(3), 273–280 (2007)CrossRef

40.

Martens, T.P., Godier, A.F., Parks, J.J., et al.: Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transpl. 18(3), 297–304 (2009)CrossRef

41.

Corda, S., Samuel, J.L., Rappaport, L.: Extracellular matrix and growth factors during heart growth. Heart Fail. Rev. 5(2), 119–130 (2000)CrossRef

42.

Akins, R.E., Rockwood, D., Robinson, K.G., et al.: Three-dimensional culture alters primary cardiac cell phenotype. Tissue Eng. Part A 16(2), 629–641 (2010)

43.

Battista, S., Guarnieri, D., Borselli, C., et al.: The effect of matrix composition of 3D constructs on embryonic stem cell differentiation. Biomaterials 26(31), 6194–6207 (2005)CrossRef

44.

Fomovsky, G.M., Thomopoulos, S., Holmes, J.W.: Contribution of extracellular matrix to the mechanical properties of the heart. J. Mol. Cell Cardiol. 62, 1331–1338 (2009)

45.

Bowers, S.L., Banerjee, I., Baudino, T.A.: The extracellular matrix: At the center of it all. J. Mol. Cell Cardiol. 48(3), 474–482 (2010)

46.

Mosesson, M.W.: Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 3(8), 1894–1904 (2005)CrossRef

47.

Ahmed, T.A., Dare, E.V., Hincke, M.: Fibrin: A versatile scaffold for tissue engineering applications. Tissue Eng. Part B. Rev. 14, 199–215 (2008) CrossRef

48.

Christman, K.L., Fok, H.H., Sievers, R.E., et al.: Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 10(3–4), 403–409 (2004)CrossRef

49.

Christman, K.L., Vardanian, A.J., Fang, Q., et al.: Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44(3), 654–660 (2004)CrossRef

50.

Yu, J., Christman, K.L., Chin, E., et al.: Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 137(1), 180–187 (2009)CrossRef

51.

Ryu, J.H., Kim, I.K., Cho, S.W., et al.: Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 26(3), 319–326 (2005)CrossRef

52.

Huang, N.F., Lam, A., Fang, Q., et al.: Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med. 4(4), 527–538 (2009)CrossRef

53.

Birla, R.K., Borschel, G.H., Dennis, R.G., et al.: Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng. 11(5–6), 803–813 (2005)CrossRef

54.

Birla, R.K., Dhawan, V., Dow, D.E., et al.: Cardiac cells implanted into a cylindrical, vascularized chamber in vivo: pressure generation and morphology. Biotechnol. Lett. 31(2), 191–201 (2009)CrossRef

55.

Silverstein, M.E., Keown, K., Owen, J.A., et al.: Collagen fibers as a fleece hemostatic agent. J. Trauma. 20(8), 688–694 (1980)CrossRef

56.

Kofidis, T., Akhyari, P., Wachsmann, B., et al.: A novel bioartificial myocardial tissue and its prospective use in cardiac surgery. Eur. J. Cardiothorac. Surg. 22(2), 238–243 (2002)CrossRef

57.

Kofidis, T., Akhyari, P., Wachsmann, B., et al.: Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. Tissue Eng. 9(3), 517–523 (2003)CrossRef

58.

Gaballa, M.A., Sunkomat, J.N., Thai, H., et al.: Grafting an acellular 3-dimensional collagen scaffold onto a non-transmural infarcted myocardium induces neo-angiogenesis and reduces cardiac remodeling. J. Heart Lung Transpl. 25(8), 946–954 (2006)CrossRef

59.

Cortes-Morichetti, M., Frati, G., Schussler, O., et al.: Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng. 13(11), 2681–2687 (2007)CrossRef

60.

Chachques, J.C., Trainini, J.C., Lago, N., et al.: Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transpl. 16(9), 927–934 (2007)CrossRef

61.

Chachques, J.C., Trainini, J.C., Lago, N., et al.: Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Ann. Thorac. Surg. 85(3), 901–908 (2008)CrossRef

62.

Schussler, O., Coirault, C., Louis-Tisserand, M., et al.: Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nat. Clin. Pract. Cardiovasc. Med. 6(3), 240–249 (2009)CrossRef

63.

Huang, N.F., Yu, J., Sievers, R., et al.: Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng. 11(11–12), 1860–1866 (2005)CrossRef

64.

Dai, W., Wold, L.E., Dow, J.S., et al.: Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J. Am. Coll. Cardiol. 46(4), 714–719 (2005)CrossRef

65.

Stern, R., Asari, A.A., Sugahara, K.N.: Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 85(8), 699–715 (2006)CrossRef

66.

Khademhosseini, A., Eng, G., Yeh, J., et al.: Microfluidic patterning for fabrication of contractile cardiac organoids. Biomed. Microdevices 9(2), 149–157 (2007)CrossRef

67.

Ventura, C., Cantoni, S., Bianchi, F., et al.: Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J. Biol. Chem. 282(19), 14243–14252 (2007)CrossRef

68.

Lionetti, V., Cantoni, S., Cavallini, C., et al.: Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. J. Biol. Chem. 285(13), 9949–9961 (2010)CrossRef

69.

Leor, J., Aboulafia-Etzion, S., Dar, A., et al.: Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102(19 Suppl 3), III56–III61 (2000)

70.

Amir, G., Miller, L., Shachar, M., et al.: Evaluation of a peritoneal-generated cardiac patch in a rat model of heterotopic heart transplantation. Cell Transpl. 18(3), 275–282 (2009)CrossRef

71.

Dvir, T., Kedem, A., Ruvinov, E., et al.: Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl. Acad. Sci. U S A. 106(35), 14990–14995 (2009)CrossRef

72.

Landa, N., Miller, L., Feinberg, M.S., et al.: Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 117(11), 1388–1396 (2008)CrossRef

73.

Hao, X., Silva, E.A., Mansson-Broberg, A., et al.: Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc. Res. 75(1), 178–185 (2007)CrossRef

74.

Tsur-Gang, O., Ruvinov, E., Landa, N., et al.: The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials 30(2), 189–195 (2009)CrossRef

75.

Yu, J., Gu, Y., Du, K.T., et al.: The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials 30(5), 751–756 (2009)CrossRef

76.

Zimmermann, W.H., Fink, C., Kralisch, D., et al.: Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 68(1), 106–114 (2000)CrossRef

77.

Zimmermann, W.H., Schneiderbanger, K., Schubert, P., et al.: Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90(2), 223–230 (2002)CrossRef

78.

Zimmermann, W.H., Didie, M., Wasmeier, G.H., et al.: Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106(12 Suppl 1), I151–I157 (2002)

79.

Zimmermann, W.H., Melnychenko, I., Wasmeier, G., et al.: Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12(4), 452–458 (2006)CrossRef

80.

Naito, H., Melnychenko, I., Didie, M., et al.: Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114(Suppl 1), I72–I78 (2006)

81.

Yildirim, Y., Naito, H., Didie, M., et al.: Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 116(Suppl 11), I16–I23 (2007)

82.

Guo, X.M., Zhao, Y.S., Chang, H.X., et al.: Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation 113(18), 2229–2237 (2006)CrossRef

83.

Shimizu, T., Yamato, M., Kikuchi, A., et al.: Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature-responsive culture dishes augments the pulsatile amplitude. Tissue Eng. 7(2), 141–151 (2001)CrossRef

84.

Shimizu, T., Yamato, M., Isoi, Y., et al.: Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 90(3), e40 (2002)CrossRef

85.

Shimizu, T., Sekine, H., Isoi, Y., et al.: Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng. 12(3), 499–507 (2006)CrossRef

86.

Sekine, H., Shimizu, T., Yang, J., et al.: Pulsatile myocardial tubes fabricated with cell sheet engineering. Circulation 114(Suppl 1), I87–I93 (2006)

87.

Sekine, H., Shimizu, T., Kosaka, S., et al.: Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. J. Heart Lung Transpl. 25(3), 324–332 (2006)CrossRef

88.

Miyahara, Y., Nagaya, N., Kataoka, M., et al.: Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12(4), 459–465 (2006)CrossRef

89.

Sekine, H., Shimizu, T., Hobo, K., et al.: Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 118(Suppl 14), S145–S152 (2008)CrossRef

90.

Badylak, S., Obermiller, J., Geddes, L., et al.: Extracellular matrix for myocardial repair. Heart Surg. Forum. 6(2), E20–E26 (2003)

91.

Robinson, K.A., Li, J., Mathison, M., et al.: Extracellular matrix scaffold for cardiac repair. Circulation 112(Suppl 9), I135–I143 (2005)

92.

Kochupura, P.V., Azeloglu, E.U., Kelly, D.J., et al.: Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 112(Suppl 9), I144–I149 (2005)

93.

Badylak, S.F., Kochupura, P.V., Cohen, I.S., et al.: The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transpl. (15 Suppl 1), S29–S40 (2006)CrossRef

94.

Kelly, D.J., Rosen, A.B., Schuldt, A.J., et al.: Increased myocyte content and mechanical function within a tissue-engineered myocardial patch following implantation. Tissue Eng. Part A 15(8), 2189–2201 (2009)CrossRef

95.

Potapova, I.A., Doronin, S.V., Kelly, D.J., et al.: Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage. Am. J. Physiol. Heart Circ. Physiol. 295(6), H2257–H2263 (2008)CrossRef

96.

Tan, M.Y., Zhi, W., Wei, R.Q., et al.: Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 30(19), 3234–3240 (2009)CrossRef

97.

Singelyn, J.M., DeQuach, J.A., Seif-Naraghi, S.B., et al.: Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials 30(29), 5409–5416 (2009)CrossRef

98.

Eitan, Y., Sarig, U., Dahan, N., et al.: Acellular cardiac extracellular matrix as a scaffold for tissue engineering: In vitro cell support, remodeling and biocompatibility. Tissue. Eng. Part C Methods 16(4), 671–683 (2010)

99.

Seif-Naraghi, S.B., Salvatore, M.A., Schup-Magoffin, P.J., et al.: Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng. Part A 16(6), 2017–2027 (2010)

100.

Crapo, P.M., Wang, Y.: Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering. Acta. Biomater. 6(6), 2091–2096 (2010)

101.

Ott, H.C., Matthiesen, T.S., Goh, S.K., et al.: Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat. Med. 14(2), 213–221 (2008)CrossRef

102.

Bursac, N., Papadaki, M., Cohen, R.J., et al.: Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol. 277(2 Pt 2), H433–H444 (1999)

103.

Papadaki, M., Bursac, N., Langer, R., et al.: Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am. J. Physiol. Heart Circ. Physiol. 280(1), H168–H178 (2001)

104.

Carrier, R.L., Papadaki, M., Rupnick, M., et al.: Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol. Bioeng. 64(5), 580–589 (1999)CrossRef

105.

Lo, H., Kadiyala, S., Guggino, S.E., et al.: Poly(L-lactic acid) foams with cell seeding and controlled-release capacity. J. Biomed. Mater. Res. 30(4), 475–484 (1996)CrossRef

106.

McDevitt, T.C., Angello, J.C., Whitney, M.L., et al.: In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces. J. Biomed. Mater. Res. 60(3), 472–479 (2002)CrossRef

107.

Zong, X., Bien, H., Chung, C.Y., et al.: Electrospun fine-textured scaffolds for heart tissue constructs. Biomaterials 26(26), 5330–5338 (2005)CrossRef

108.

Bostman, O.M.: Intense granulomatous inflammatory lesions associated with absorbable internal fixation devices made of polyglycolide in ankle fractures. Clin. Orthop. Relat. Res. 278, 193–199 (1992)

109.

Taylor, M.S., Daniels, A.U., Andriano, K.P., et al.: Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J. Appl. Biomater. 5(2), 151–157 (1994)CrossRef

110.

McDevitt, T.C., Woodhouse, K.A., Hauschka, S.D., et al.: Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J. Biomed. Mater. Res. A 66(3), 586–595 (2003)CrossRef

111.

Siepe, M., Giraud, M.N., Liljensten, E., et al.: Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair. Artif. Organs 31(6), 425–433 (2007)CrossRef

112.

Siepe, M., Giraud, M.N., Pavlovic, M., et al.: Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure. J. Thorac. Cardiovasc. Surg. 132(1), 124–131 (2006)

113.

Shin, M., Ishii, O., Sueda, T., et al.: Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials 25(17), 3717–3723 (2004)CrossRef

114.

Ishii, O., Shin, M., Sueda, T., et al.: In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. J. Thorac. Cardiovasc. Surg. 130(5), 1358–1363 (2005)CrossRef

115.

Ashton, R.S., Banerjee, A., Punyani, S., et al.: Scaffolds based on degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell culture. Biomaterials 28(36), 5518–5525 (2007)CrossRef

116.

Dai, N.T., Williamson, M.R., Khammo, N., et al.: Composite cell support membranes based on collagen and polycaprolactone for tissue engineering of skin. Biomaterials 25(18), 4263–4271 (2004)CrossRef

117.

Mei, N., Chen, G., Zhou, P., et al.: Biocompatibility of poly(epsilon-caprolactone) scaffold modified by chitosan–the fibroblasts proliferation in vitro. J. Biomater. Appl. 19(4), 323–339 (2005)CrossRef

118.

Pankajakshan, D., Krishnan, V.K., Krishnan, L.K.: Vascular tissue generation in response to signaling molecules integrated with a novel poly(epsilon-caprolactone)-fibrin hybrid scaffold. J. Tissue Eng. Regen. Med. 1(5), 389–397 (2007)CrossRef

119.

Ma, Z., He, W., Yong, T., et al.: Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell orientation. Tissue Eng. 11(7–8), 1149–1158 (2005)CrossRef

120.

Chen, Q.Z., Ishii, H., Thouas, G.A., et al.: An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart. Biomaterials 31(14), 3885–3893 (2010)CrossRef

Title: Tissue Engineering for Cardiac Regeneration
Authors: Roberto Gaetani
Pieter A. F. Doevendans
Elisa Messina
Joost P. G. Sluijter
Publisher: Springer Berlin Heidelberg
Book: Myocardial Tissue Engineering
Print ISBN: 978-3-642-18055-2

Electronic ISBN: 978-3-642-18056-9

Copyright Year: 2011
DOI: https://doi.org/10.1007/8415_2011_82